USSTOCK.TODAY
Regular Market
Log in Sign up

Kaplan Fox & Kilsheimer LLP Investigating Potential Securities Law Violations by Medline Inc.

Newsfile · ·by G4

MDLN Medline Inc
$40.71 +2.70%
View chart & analysis →
  1. 1Kaplan Fox & Kilsheimer LLP is investigating potential violations of securities laws by Medline Inc.
  2. 2The FDA stated that Medline failed to thoroughly investigate microbial contamination incidents in finished drug products.
  3. 3Medline's share price fell by $2.56, recording a closing price of $33.19 per share on June 2, 2026.

So what's the key point?

A law firm is investigating whether Medline violated the law. The stock price dropped by $2.56 due to issues regarding the investigation of drug contamination incidents.

Source Newsfile · View original ↗

Related 3-line summaries

Medline cuts annual adjusted EBITDA guidance by approximately $200 million Earnings Whispers · Oct 28Kaplan Fox Announces Filing of Class Action Securities Lawsuit Against Embecta (EMBC) Newsfile +4 · Aug 10Iron Mountain Reports Q2 Profit of $100.4 Million Associated Press +3 · Aug 5
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news